For unknown reasons, intensive insulin therapy not only normalizes the elevated blood glucose levels but also, and remarkably, increases the survival of non-diabetics and diabetics with critical (ICU-type) illnesses. Our basic premise is that (1) hyperglycemia increases inflammation and acute lung injury (ALI) and (2) insulin therapy decreases inflammation and ALI. Our specific hypothesis is that hyperglycemia increases cytokines which increase mononuclear phagocyte (MNP) xanthine oxidoreductase (XOR) activity, NF-(B activation and IL-8 production which, in turn, increase neutrophil (PMN) recruitment and ALI severity;the corollary to this hypothesis is that insulin has an opposing effect on this mechanism. Our preliminary data supports this approach: 1. XOR increases in newly recruited MNP which are recovered from lungs of rats insufflated with IL-1 and IFN-( and MNP XOR can promote recruitment of PMN into lungs of control rats. 2. Hyperglycemia increases ALI, CINC (rat IL-8 equivalent) levels and PMN recruitment in lungs of rats insufflated with IL-1 and IFN-( in vivo and induces cytokines that up-regulate XOR expression in vitro. 3. Insulin therapy decreases MNP C/EBPp activity, MNP XOR activity, MNP NF-(B activity, PMN recruitment and injury in lungs of rats insufflated with IL-1 and IFN-( in vivo. 4. Cytokines, MAP kinases and C/EBP-3 increase the XOR expression of epithelial cells in vitro. Our three specific aims are the following:
Specific Aim 1 : To determine the effect of glucose infusion and/or insulin therapy on the ability of MNP to recruit PMN into the lung in vivo.
Specific Aim 2 : To determine if alterations in XOR activity in MNP contribute to the different PMN recruiting activities of MNP from rats given glucose infusions and/or insulin therapy.
Specific Aim 3 : To determine the mechanism by which glucose infusion and/or insulin therapy regulate MNP XOR expression and ROS signaling. Significance: This translational research will determine the effect of hyperglycemia and/or insulin therapy on ALI using an innovative, new technology that measures blood glucose levels continuously and non-invasively. By defining the underlying mechanisms for this life-saving clinical finding, we will improve understanding of the pathogenesis of ALI and find better strategies for controlling hyperglycemia, giving insulin and/or using other interventions to treat and prevent ALI.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL045582-16
Application #
7779985
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Harabin, Andrea L
Project Start
1992-02-10
Project End
2011-12-31
Budget Start
2010-04-01
Budget End
2011-12-31
Support Year
16
Fiscal Year
2010
Total Cost
$385,000
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Repine, John E; Elkins, Nancy D (2012) Effect of ergothioneine on acute lung injury and inflammation in cytokine insufflated rats. Prev Med 54 Suppl:S79-82
Gibbings, Sophie; Elkins, Nancy D; Fitzgerald, Hillary et al. (2011) Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor-{gamma} sumoylation, and HIF-1{alpha}. J Biol Chem 286:961-75
Stupic, K F; Elkins, N D; Pavlovskaya, G E et al. (2011) Effects of pulmonary inhalation on hyperpolarized krypton-83 magnetic resonance T1 relaxation. Phys Med Biol 56:3731-48
Fini, Mehdi A; Monks, Jenifer; Farabaugh, Susan M et al. (2011) Contribution of xanthine oxidoreductase to mammary epithelial and breast cancer cell differentiation in part modulates inhibitor of differentiation-1. Mol Cancer Res 9:1242-54
Fini, Mehdi A; Orchard-Webb, David; Kosmider, Beata et al. (2008) Migratory activity of human breast cancer cells is modulated by differential expression of xanthine oxidoreductase. J Cell Biochem 105:1008-26
Roberts, Laura E; Fini, Mehdi A; Derkash, Noi et al. (2007) PD98059 enhanced insulin, cytokine, and growth factor activation of xanthine oxidoreductase in epithelial cells involves STAT3 and the glucocorticoid receptor. J Cell Biochem 101:1567-87
Seymour, Katherine J; Roberts, Laura E; Fini, Mehdi A et al. (2006) Stress activation of mammary epithelial cell xanthine oxidoreductase is mediated by p38 MAPK and CCAAT/enhancer-binding protein-beta. J Biol Chem 281:8545-58
Hybertson, Brooks M; Chung, Jin H; Fini, Mehdi A et al. (2005) Aerosol-administered alpha-tocopherol attenuates lung inflammation in rats given lipopolysaccharide intratracheally. Exp Lung Res 31:283-94
McManaman, James L; Palmer, Carol A; Anderson, Steven et al. (2004) Regulation of milk lipid formation and secretion in the mouse mammary gland. Adv Exp Med Biol 554:263-79
Yoon-yub, Park; Hybertson, Brooks; Wright, Richard et al. (2004) Serum ferritin elevation and acute lung injury in rats subjected to hemorrhage: reduction by mepacrine treatment. Exp Lung Res 30:571-84

Showing the most recent 10 out of 34 publications